Sergey Lukyanov
Research Subjects
Sergey Lukyanov has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Konstantin Gennadyevich Shapovalov
Chita State Medical Academy, Chita, Russia
8 shared publications - Boris Il'Ich Kuznik
Chita State Medical Academy
4 shared publications E. N. Romanova
4 shared publications- Ludmila Sergeevna Kazantseva
Regional Clinical Infectious Diseases Hospital
4 shared publications - Pavel P. Tereshkov
Chita State Medical Academy
4 shared publications - Valerii A. Konnov
Chita State Medical Academy
4 shared publications
Latest Publications
- 27 May 2026
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (2) , 118-128
Indicators of the innate immune system in patients with severe COVID-19 and their role in the development of coagulopathy
SARS-CoV-2 is one of the few viruses that cause blood coagulation disorders. The pathogenesis of coagulopathies in COVID-19 is polyetiological: cytokine storm, NETosis, dysfunction of the renin-angiotensin system, thrombotic microangiopathy, disseminated intravascular coagulation (DIC), and hypofibrinolysis. However, the role of the immune system in the development of these disorders remains insufficiently described. The aim . To characterize the role of the innate immune system in the development of coagulopathies in patients with severe COVID-19. Methods . The study included a cohort of 103 patients with severe COVID-19 receiving anticoagulant therapy and undergoing treatment in Chita, Russia. Hemostasis was assessed using thrombodynamics testing, as well as measurement of fibrinogen, D-dimer, tissue plasminogen activator (tPA), and plasminogen activator inhibitor-1 (PAI-1). All patients with SARS-CoV-2 were stratified into four subgroups based on their hemostatic status. Levels of tissue factor (TF), D-dimer, tPA, PAI-1, myeloperoxidase (MPO), matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and cystatin C were determined by flow cytometry. Results . In the pronounced hypercoagulation and hypercoagulation groups, elevated fibrinogen levels were observed, along with a parallel increase in tPA concentration and a sharp rise in PAI-1 levels. Meanwhile, maximal TF-values were recorded in patients with hypocoagulation. MMP-2 levels were lower than those in the control group in all COVID-19 patients, but progressively increased from normocoagulation to hypocoagulation, reaching a maximum in the latter group. MMP-9 and MPO concentrations were elevated across all groups, peaking in the normocoagulation group. Cystatin C concentration was increased in all patients. Conclusion . Severe COVID-19 is associated with the development of thrombotic coagulopathy, driven by the formation of a vicious cycle of “thromboinflammation,” in which hemostatic disorders and systemic inflammatory response mutually reinforce each other.
- 27 May 2026
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (2) , 118-128
Indicators of the innate immune system in patients with severe COVID-19 and their role in the development of coagulopathy
SARS-CoV-2 is one of the few viruses that cause blood coagulation disorders. The pathogenesis of coagulopathies in COVID-19 is polyetiological: cytokine storm, NETosis, dysfunction of the renin-angiotensin system, thrombotic microangiopathy, disseminated intravascular coagulation (DIC), and hypofibrinolysis. However, the role of the immune system in the development of these disorders remains insufficiently described. The aim . To characterize the role of the innate immune system in the development of coagulopathies in patients with severe COVID-19. Methods . The study included a cohort of 103 patients with severe COVID-19 receiving anticoagulant therapy and undergoing treatment in Chita, Russia. Hemostasis was assessed using thrombodynamics testing, as well as measurement of fibrinogen, D-dimer, tissue plasminogen activator (tPA), and plasminogen activator inhibitor-1 (PAI-1). All patients with SARS-CoV-2 were stratified into four subgroups based on their hemostatic status. Levels of tissue factor (TF), D-dimer, tPA, PAI-1, myeloperoxidase (MPO), matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and cystatin C were determined by flow cytometry. Results . In the pronounced hypercoagulation and hypercoagulation groups, elevated fibrinogen levels were observed, along with a parallel increase in tPA concentration and a sharp rise in PAI-1 levels. Meanwhile, maximal TF-values were recorded in patients with hypocoagulation. MMP-2 levels were lower than those in the control group in all COVID-19 patients, but progressively increased from normocoagulation to hypocoagulation, reaching a maximum in the latter group. MMP-9 and MPO concentrations were elevated across all groups, peaking in the normocoagulation group. Cystatin C concentration was increased in all patients. Conclusion . Severe COVID-19 is associated with the development of thrombotic coagulopathy, driven by the formation of a vicious cycle of “thromboinflammation,” in which hemostatic disorders and systemic inflammatory response mutually reinforce each other.
- Open Access
- 23 February 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 23 (1) , 77-87
Ex situ and in situ training of admission department staff of psychological first aid for acute psychological reactions to stress in relatives of intensive care patients
Introduction . Training of admission department registrars in psychological first aid for relatives of patients with life-threatening conditions is a pressing issue in the modern healthcare system. The objective was to establish the effectiveness of the educational and methodological complex of the residency «Anesthesiology and Resuscitation» on psychological first aid for relatives of intensive care patients in developing universal competence in interacting with relatives of patients during the training of admission department registrars. Materials and methods . Two sessions were held with 8 registrars in a simulation center, and the 3 rd simulation session was held at the registrars’ workplace. Simulated relatives of patients played apathy, fear, hysteria, crying, anxiety, and aggression. The scores of the checklists according to the psychological first aid algorithm were compared at all sessions for each psychological reaction and for each session for all reactions. Results . No differences in scores were found for apathy and crying. For hysteria, aggression, and anxiety, there were more scores at the 3rd session. In case of fear, the points at the 3 rd session were higher than at the 2 nd and 1 st , at the 2nd session, they were higher than at the 1 st . There was no differences between psychological reactions at the 2 nd and 3 rd sessions. At the 1 st session, the points for apathy were higher than for other reactions, except for crying, the points for crying exceeded the points for anxiety and fear. Conclusion . The educational and methodological complex of the residency «Anesthesiology and Resuscitation» of psychological first aid for relatives of intensive care patients improves the results of simulation training in the formation of universal competence in interacting with relatives of patients. The methodology of «in situ simulation» sessions is applicable in the formation of such competence.
- 23 February 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 23 (1) , 77-87
Open AccessEx situ and in situ training of admission department staff of psychological first aid for acute psychological reactions to stress in relatives of intensive care patients
Introduction . Training of admission department registrars in psychological first aid for relatives of patients with life-threatening conditions is a pressing issue in the modern healthcare system. The objective was to establish the effectiveness of the educational and methodological complex of the residency «Anesthesiology and Resuscitation» on psychological first aid for relatives of intensive care patients in developing universal competence in interacting with relatives of patients during the training of admission department registrars. Materials and methods . Two sessions were held with 8 registrars in a simulation center, and the 3 rd simulation session was held at the registrars’ workplace. Simulated relatives of patients played apathy, fear, hysteria, crying, anxiety, and aggression. The scores of the checklists according to the psychological first aid algorithm were compared at all sessions for each psychological reaction and for each session for all reactions. Results . No differences in scores were found for apathy and crying. For hysteria, aggression, and anxiety, there were more scores at the 3rd session. In case of fear, the points at the 3 rd session were higher than at the 2 nd and 1 st , at the 2nd session, they were higher than at the 1 st . There was no differences between psychological reactions at the 2 nd and 3 rd sessions. At the 1 st session, the points for apathy were higher than for other reactions, except for crying, the points for crying exceeded the points for anxiety and fear. Conclusion . The educational and methodological complex of the residency «Anesthesiology and Resuscitation» of psychological first aid for relatives of intensive care patients improves the results of simulation training in the formation of universal competence in interacting with relatives of patients. The methodology of «in situ simulation» sessions is applicable in the formation of such competence.
- Open Access
- 6 July 2023
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (3) , 198-204
Predictive role of erythrocytes in assessment of COVID-19 outcomes
Introduction. The search for affordable and accurate predictors of the outcome of COVID-19 is extremely important, as it provides the possibility to effectively correct the patient treatment tactics. Aim of the study. To develop simple and accurate criteria based on the dynamics of red blood counts that predict the outcome of COVID-19. Materials and methods. Observations were carried out in 125 patients with severe and extremely severe COVID-19, in whom indicators characterizing the state of red blood were determined in dynamics on days 1, 5, 7, 10, 14 and 21 after the hospitalization. ROC analysis was performed to calculate the threshold predictive values for survival and mortality. Results. The total number of erythrocytes and the level of hemoglobin in severe and extremely severe patients did not go beyond the acceptable limits, although showed a tendency to decrease in the group of fatal cases. On the 1st and 21st days, the number of MacroR in the deceased patients was reduced compared to those in group of survivors. It has been established that the RDW-CV test can predict the outcome of the COVID-19 with a high degree of probability at a relatively early stage of disease. RDW-SD test can be an additional predictive criterion of COVID-19 outcome. Conclusion. The RDW-CV test can be used as an effective predictor of disease outcome in patients with severe COVID-19.
- 6 July 2023
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (3) , 198-204
Open AccessPredictive role of erythrocytes in assessment of COVID-19 outcomes
Introduction. The search for affordable and accurate predictors of the outcome of COVID-19 is extremely important, as it provides the possibility to effectively correct the patient treatment tactics. Aim of the study. To develop simple and accurate criteria based on the dynamics of red blood counts that predict the outcome of COVID-19. Materials and methods. Observations were carried out in 125 patients with severe and extremely severe COVID-19, in whom indicators characterizing the state of red blood were determined in dynamics on days 1, 5, 7, 10, 14 and 21 after the hospitalization. ROC analysis was performed to calculate the threshold predictive values for survival and mortality. Results. The total number of erythrocytes and the level of hemoglobin in severe and extremely severe patients did not go beyond the acceptable limits, although showed a tendency to decrease in the group of fatal cases. On the 1st and 21st days, the number of MacroR in the deceased patients was reduced compared to those in group of survivors. It has been established that the RDW-CV test can predict the outcome of the COVID-19 with a high degree of probability at a relatively early stage of disease. RDW-SD test can be an additional predictive criterion of COVID-19 outcome. Conclusion. The RDW-CV test can be used as an effective predictor of disease outcome in patients with severe COVID-19.
- 16 April 2022
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 67 (1-2) , 32-38
Neuroprotective Therapy for Neurological Complications of the Novel Coronavirus Infection COVID-19
COVID-19 is a global contemporary issue. Acute hypoxic respiratory failure and associated multiple organ dysfunction are the basics of the new disease pathogenesis. An important characteristic of COVID-19 is the damage to the central nervous system, which determines the peculiarities of the clinical course. In the case of vascular complications (ischemic stroke, encephalopathy, delirium) the prognosis of the disease is more severe. The article presents the experience of a large Russian monohospital in observation and treatment of patients with COVID-19 and neurological complications. It also shows the prospect of neuroprotective therapy in this category of patients.
- 16 April 2022
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 67 (1-2) , 32-38
Neuroprotective Therapy for Neurological Complications of the Novel Coronavirus Infection COVID-19
COVID-19 is a global contemporary issue. Acute hypoxic respiratory failure and associated multiple organ dysfunction are the basics of the new disease pathogenesis. An important characteristic of COVID-19 is the damage to the central nervous system, which determines the peculiarities of the clinical course. In the case of vascular complications (ischemic stroke, encephalopathy, delirium) the prognosis of the disease is more severe. The article presents the experience of a large Russian monohospital in observation and treatment of patients with COVID-19 and neurological complications. It also shows the prospect of neuroprotective therapy in this category of patients.
- Open Access
- 31 March 2022
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 7 (1) , 70-77-77
Inflammatory markers and organ dysfunction in patients with severe influenza A (H1N1) virus-associated pneumonia
Aim. To assess inflammatory markers and organ dysfunction in patients with severe influenza A (H1N1) virus-associated pneumonia.Materials and Methods. The study included 50 patients (median age 47 (38-62) years, 24 males and 26 females) with severe influenza A (H1N1) virus-associated pneumonia. We analysed the clinicopathological data as well as complete blood count and biochemical profile. Organ dysfunction was assessed using SOFA and qSOFA scales.Results. The prevalence of multiple organ dysfunction syndrome in patients with severe influenza A (H1N1) virus-associated pneumonia was 46% (23/50 patients). Patients frequently suffered from insufficient oxygenation, impaired coagulation, altered haemodynamics, and central nervous system dysfunction. Out of 23 patients with multiple organ dysfunction syndrome, 10 (43.5%) suffered from reduced oxygenation and excessive coagulation, while 6 (26.0%) had all mentioned syndromes combined. Thrombocytopenia was detected as early as at day 1-2 of the disease and was further accompanied by an increase in the erythrocyte sedimentation rate and white blood cell count from day 2 to day 8. An increase in acute-phase proteins (C-reactive protein and fibrinogen) was noted at the day 5-6 of the disease.Conclusion. In patients with severe influenza A (H1N1) virus-associated pneumonia, an early systemic inflammatory response evolves into an uncontrolled multiple organ dysfunction syndrome by day 7-8 of infection.
- 31 March 2022
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 7 (1) , 70-77-77
Open AccessInflammatory markers and organ dysfunction in patients with severe influenza A (H1N1) virus-associated pneumonia
Aim. To assess inflammatory markers and organ dysfunction in patients with severe influenza A (H1N1) virus-associated pneumonia.Materials and Methods. The study included 50 patients (median age 47 (38-62) years, 24 males and 26 females) with severe influenza A (H1N1) virus-associated pneumonia. We analysed the clinicopathological data as well as complete blood count and biochemical profile. Organ dysfunction was assessed using SOFA and qSOFA scales.Results. The prevalence of multiple organ dysfunction syndrome in patients with severe influenza A (H1N1) virus-associated pneumonia was 46% (23/50 patients). Patients frequently suffered from insufficient oxygenation, impaired coagulation, altered haemodynamics, and central nervous system dysfunction. Out of 23 patients with multiple organ dysfunction syndrome, 10 (43.5%) suffered from reduced oxygenation and excessive coagulation, while 6 (26.0%) had all mentioned syndromes combined. Thrombocytopenia was detected as early as at day 1-2 of the disease and was further accompanied by an increase in the erythrocyte sedimentation rate and white blood cell count from day 2 to day 8. An increase in acute-phase proteins (C-reactive protein and fibrinogen) was noted at the day 5-6 of the disease.Conclusion. In patients with severe influenza A (H1N1) virus-associated pneumonia, an early systemic inflammatory response evolves into an uncontrolled multiple organ dysfunction syndrome by day 7-8 of infection.
- Open Access
- 1 October 2021
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 11 (4) , 368-376
Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients
Peptide drug Thymalin, isolated from the calve thymus, is successfully used for the treatment of various immunopathologies, including those in older age groups. The molecular mechanism of the Thymalin immunoprotective action is due to the effects of the short peptides KE, EW, EDP in its composition. These short peptides can specifically bind to double-stranded DNA and/or histone proteins and regulate gene expression, synthesis of immune system proteins, activity of gerontogenes, and stimulate stem cell differentiation. Regulation of immunogenesis is a key factor preventing the development of the “cytokine storm” that develops in severe COVID-19. The purpose of this work is to study the effectiveness of Thymalin in severe COVID-19 in older patients. Patients administered with Thymalin against the background of a standard therapy (n = 36) manifested a more rapid clinical improvement, higher proportions of recovery from lymphopenia, faster normalization of the concentration of C-reactive protein, D-dimer, the number of lymphocytes and NK-cells in the blood, compared to patients who received a standard therapy only (n = 44). Thymalin halved hospital mortality in older patients with severe COVID-19. The results obtained showed the effectiveness of Thymalin administration in the complex therapy of patients with severe COVID-19.
- 1 October 2021
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 11 (4) , 368-376
Open AccessPeptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients
Peptide drug Thymalin, isolated from the calve thymus, is successfully used for the treatment of various immunopathologies, including those in older age groups. The molecular mechanism of the Thymalin immunoprotective action is due to the effects of the short peptides KE, EW, EDP in its composition. These short peptides can specifically bind to double-stranded DNA and/or histone proteins and regulate gene expression, synthesis of immune system proteins, activity of gerontogenes, and stimulate stem cell differentiation. Regulation of immunogenesis is a key factor preventing the development of the “cytokine storm” that develops in severe COVID-19. The purpose of this work is to study the effectiveness of Thymalin in severe COVID-19 in older patients. Patients administered with Thymalin against the background of a standard therapy (n = 36) manifested a more rapid clinical improvement, higher proportions of recovery from lymphopenia, faster normalization of the concentration of C-reactive protein, D-dimer, the number of lymphocytes and NK-cells in the blood, compared to patients who received a standard therapy only (n = 44). Thymalin halved hospital mortality in older patients with severe COVID-19. The results obtained showed the effectiveness of Thymalin administration in the complex therapy of patients with severe COVID-19.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA3667
Thymalin as an immunomodulation option in severe COVID-19
Introduction: Most COVID-19 cases demonstrated severe lymphocytopenia, especially in severe cases, which might lead to ineffective antiviral immunity. Aims and objectives: The purpose of the study was to identify the role of T-cells supression in severe COVID-19 and the opportunities of its correction. Methods: 80 patients with severe COVID-19 were prospectively enrollled in study in period from April to October 2020 in Chita Clinical Hospital. Enrollement criteria: positive test for SARS-CoV-2 by RT-PCR; typical pattern of COVID-19 on CT-scans. The enrolled patients were randomly separated into 2 groups: I group, which received thymalin 10 mg/2ml 0.9% NaCl daily intramuscularly for 10 days + standard-of-care (SoC) treatment, and the control group (II group), which received placebo twice daily for 10 days with SoC treatment. Results: It was found the patients in I and II groups were initially comparable in age, severity of the disease and need in respiratory support (NiV/IMV). On the day 10th after randomisation the level of CD4+ cells was higher in group I on 10th day: 333±80 VS 193±135 (p=0.011). Conclusion: The lower level of CD4-lymphocytes on 10th day of admission was associated with worse outcome in severe COVID-19. The use of thymaline can probably improve T-cells level and the clinical outcomes.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA3667
Thymalin as an immunomodulation option in severe COVID-19
Introduction: Most COVID-19 cases demonstrated severe lymphocytopenia, especially in severe cases, which might lead to ineffective antiviral immunity. Aims and objectives: The purpose of the study was to identify the role of T-cells supression in severe COVID-19 and the opportunities of its correction. Methods: 80 patients with severe COVID-19 were prospectively enrollled in study in period from April to October 2020 in Chita Clinical Hospital. Enrollement criteria: positive test for SARS-CoV-2 by RT-PCR; typical pattern of COVID-19 on CT-scans. The enrolled patients were randomly separated into 2 groups: I group, which received thymalin 10 mg/2ml 0.9% NaCl daily intramuscularly for 10 days + standard-of-care (SoC) treatment, and the control group (II group), which received placebo twice daily for 10 days with SoC treatment. Results: It was found the patients in I and II groups were initially comparable in age, severity of the disease and need in respiratory support (NiV/IMV). On the day 10th after randomisation the level of CD4+ cells was higher in group I on 10th day: 333±80 VS 193±135 (p=0.011). Conclusion: The lower level of CD4-lymphocytes on 10th day of admission was associated with worse outcome in severe COVID-19. The use of thymaline can probably improve T-cells level and the clinical outcomes.
- Open Access
- 17 August 2021
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 6 (3) , 53-59
Acute kidney injury in patients with pneumonia with A/H1N1 influenza
Острое почечное повреждение у больных пневмониями на фоне гриппа A/H1N1
- 17 August 2021
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 6 (3) , 53-59
Open AccessAcute kidney injury in patients with pneumonia with A/H1N1 influenza
Острое почечное повреждение у больных пневмониями на фоне гриппа A/H1N1
- Open Access
- 17 August 2021
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 6 (3) , 70-76
Role of proteins MRP8 (S100A8) and MRP14 (S100A9) in the development of critical condition in patients with pneumonia with A/H1N1 influenza
Роль белков MRP8 (S100A8) и MRP14 (S100A9) в развитии критического состояния у больных пневмонией на фоне гриппа A/H1N1
- 17 August 2021
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 6 (3) , 70-76
Open AccessRole of proteins MRP8 (S100A8) and MRP14 (S100A9) in the development of critical condition in patients with pneumonia with A/H1N1 influenza
Роль белков MRP8 (S100A8) и MRP14 (S100A9) в развитии критического состояния у больных пневмонией на фоне гриппа A/H1N1
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Rhabdomyolysis in severe viral pneumonias in 2019
Introduction: The one of the distinguishing features of pneumonias with viral origin is an elevated level of muscle damage markers such as creatine phosphate kinase (CK), lactate dehydrogenase (LDH) and myoglobin. It was firstly found in flu A(H1N1)pdm in 2009, and the last time in 2020 in patients with COVID-19. Aims and Objectives: The main purpose of the study was the analysis of the role of elevated muscle damage markers in patients with severe pneumonia of viral origin. Methods: 100 patients with severe pneumonias were examined in 2019. The ethiology verification was performed using polymeraze chain reaction (100% positive result - RNA virus A(H1N1)/09). The myoglobin level was assesed using flow-cytometry multiplex panel (BioLegend). Results: The average age of the patients was 53 [48; 63] years, gender proportion: 56% male, 44% - female. From the whole group ARDS was confirmed in 32% pts. Of the whole group 25 patients died, 75 survivied. CK and LDH levels were significantly higher in patients who died, than those in survivors. The level of serum myoglobin was an independent factor of mortality in such patients. Using ROC-analysis the level of serum myoglobin had a greatest area under curve (AUC) about 0.801. Conclusion: An independent unfavorable factor of lethality in severe pneumonias, associated with influenza A(H1N1)/09 was th level of serum myoglobin. Traditionally it was believed that this marker indicates radmiolysis, but its full significance is not yet clear enough.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Rhabdomyolysis in severe viral pneumonias in 2019
Introduction: The one of the distinguishing features of pneumonias with viral origin is an elevated level of muscle damage markers such as creatine phosphate kinase (CK), lactate dehydrogenase (LDH) and myoglobin. It was firstly found in flu A(H1N1)pdm in 2009, and the last time in 2020 in patients with COVID-19. Aims and Objectives: The main purpose of the study was the analysis of the role of elevated muscle damage markers in patients with severe pneumonia of viral origin. Methods: 100 patients with severe pneumonias were examined in 2019. The ethiology verification was performed using polymeraze chain reaction (100% positive result - RNA virus A(H1N1)/09). The myoglobin level was assesed using flow-cytometry multiplex panel (BioLegend). Results: The average age of the patients was 53 [48; 63] years, gender proportion: 56% male, 44% - female. From the whole group ARDS was confirmed in 32% pts. Of the whole group 25 patients died, 75 survivied. CK and LDH levels were significantly higher in patients who died, than those in survivors. The level of serum myoglobin was an independent factor of mortality in such patients. Using ROC-analysis the level of serum myoglobin had a greatest area under curve (AUC) about 0.801. Conclusion: An independent unfavorable factor of lethality in severe pneumonias, associated with influenza A(H1N1)/09 was th level of serum myoglobin. Traditionally it was believed that this marker indicates radmiolysis, but its full significance is not yet clear enough.